Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
KB Partners I, LP et al v. Barbier et al
Case Number:
1:11-cv-01034
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Ahmad Zavitsanos
- Boies Schiller
- Dykema Gossett
- Pomerantz LLP
- Sorrels Law
- Yetter Coleman
- Zuckerman Spaeder
Companies
Sectors & Industries:
-
September 01, 2016
Pain Therapeutics Gets Nod On $8.5M Remoxy Class Deal
A Texas federal judge on Thursday gave preliminary approval of a settlement that would pay shareholders of Pain Therapeutics Inc. up to $8.5 million and release claims the company hid from the market manufacturing issues with its pain treatment Remoxy.
-
July 08, 2015
Texas Judge Tells Remoxy Plaintiffs To Refile Class Action
A federal Texas judge on Tuesday ordered attorneys for a putative class accusing Pain Therapeutics Inc. of misleading investors about the prospects for painkiller Remoxy to refile their complaint and restart the class from the beginning in order to proceed, pushing the trial date back to March 2017.
-
November 05, 2014
Confidential Witness Denies Testimony In Remoxy Suit
Plaintiffs in a putative class action accusing Pain Therapeutics Inc. of misleading investors about the prospects for painkiller Remoxy attributed to a confidential witness statements that the man now claims he never made, the pharmaceutical company told a Texas federal court Tuesday.
-
November 20, 2012
Pain Therapeutics Can't Duck Investors' Remoxy Suit
A Texas federal judge refused Tuesday to derail a putative class action accusing Pain Therapeutics Inc. of misleading investors about the prospects for painkiller Remoxy, saying there was plausible evidence executives might have concealed damaging information about the drug.
-
September 26, 2012
Pain Therapeutics Gets Investors' Painkiller Suit Nixed
A Texas federal judge on Wednesday dismissed a class action alleging Pain Therapeutics Inc.'s brass misled investors into thinking the biopharmaceutical company's newly developed painkiller would receive U.S. Food and Drug Administration approval, when it ultimately did not.